12 Jun 2025
12:00 AM
AGM
Announcement Date: 12 Jun, 2025
21 Apr 2026
12:00 AM
Board Meeting
Agenda : Audited Result
3 Nov 2025
12:00 AM
Dividend
Dividend Amount: 28
Record Date: 10 Nov, 2025
Profit after tax for the nine months ended December 2025 rose 14% year on year to ₹789 crore, compared with ₹695 crore in the year ago period
EBITDA margin for the quarter came in at 27.8%, slightly lower than 28% recorded in the year ago period.
The company plans to launch the product after securing all necessary regulatory approvals, which are expected to be received between late 2026 and early 2027.
Ajanta Pharma reported a strong EBITDA margin of 25% in the quarter.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
